Our data would suggest that the classical activation of IFN-related pathways observed in SLE patients is highly dependent upon anti-RBP antibodies in AA SLE patients, and this dependence is not shared by EA SLE patients. Here, IFNA1 is linked to systemic lupus erythematosus.